Publications by authors named "H Balbi"

Nirsevimab: A Review.

Pediatr Allergy Immunol Pulmonol

March 2024

Article Synopsis
  • RSV is a major cause of lower respiratory infections and is particularly serious for infants, leading to a high rate of hospitalization in the US.
  • In 2023, the FDA approved two vaccines for older adults and a long-acting monoclonal antibody to help prevent severe RSV infections in infants and young children.
  • The monoclonal antibody, nirsevimab, has been endorsed for all infants under 8 months and for at-risk children aged 8 to 19 months to reduce their risk of severe RSV disease.
View Article and Find Full Text PDF

Lemierre syndrome is a condition that can have high morbidity and mortality, but if it is diagnosed early in a patient's workup, that is, in the ED, the morbidity and mortality can be significantly decreased. First described by Dr Andre Lemierre in 1936, Lemierre syndrome is a clinical condition, which presents as septic emboli in the internal jugular vein after an untreated pharyngitis. This condition can have significant morbidity and mortality; therefore, although it is not common in today's era of antimicrobials, it should still be considered and thought of to prevent the significant consequences that may occur from it.

View Article and Find Full Text PDF

A number of diverse head and neck manifestations of HIV infection have been described, including adenoidal hypertrophy. We report a series of HIV-infected children in which 9 of 18 had abnormally small or radiographically absent adenoidal tissue. This finding did not, however, seem to correlate with several parameters for the severity or stage of illness.

View Article and Find Full Text PDF